Amplia Therapeutics Ltd.ASX: ATX

Amplia Presents at E&P Healthcare Conference 2026

· Issued by Amplia Therapeutics Ltd. via ASX

Filed with ASX · · 29 pages · English

Summary by 6ix AI

Amplia Therapeutics Ltd. announced that its CEO, Dr. Chris Burns, will present at the E&P Healthcare Conference in Sydney. The presentation includes information about Amplia's pipeline of Focal Adhesion Kinase inhibitors targeting cancers, particularly pancreatic cancer.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/amplia-presents-at-eandp-healthcare-conference-2026

Release

ABN 16 165 160 841 +61 (0) 3 9123 1140 | info@ampliatx.com Level 5, 90 William Street, Melbourne VIC 3000 Australia www.ampliatx.com 16 SEPTEMBER 2026 ASX RELEASE AMPLIA PRESENTS AT E&P HEALTHCARE CONFERENCE 2026 Melbourne, Australia: Amplia Therapeutics Limited (ASX:ATX; OTCQB:INNMF), is...

Amplia Therapeutics Ltd. on 6ix

In the deck

Earlier from Amplia Therapeutics

Later from Amplia Therapeutics

All Amplia Therapeutics news releases